Molina Healthcare currently appears undervalued based on several valuation metrics. The stock holds a Zacks Rank #2, or Buy, and an A grade for Value. It trades at a price-to-earnings ratio of 9.08, well below the industry average of 18.19, and its forward P/E has ranged from 6.48 to 13.98 over the past year. The price-to-book ratio stands at 2.06 versus the industry's 2.73, while the price-to-sales ratio is 0.26 compared to the industry average of 0.35. Combined with a strong earnings outlook, these figures suggest Molina Healthcare is one of the market's strongest value stocks.
Molina Healthcare IncArticle states Molina Healthcare appears undervalued based on P/E, P/B, P/S ratios and has a Zacks Buy rating, indicating a positive valuation call.